Cargando…

Late-onset Alzheimer disease risk variants mark brain regulatory loci

OBJECTIVE: To investigate the top late-onset Alzheimer disease (LOAD) risk loci detected or confirmed by the International Genomics of Alzheimer's Project for association with brain gene expression levels to identify variants that influence Alzheimer disease (AD) risk through gene expression re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Allen, Mariet, Kachadoorian, Michaela, Carrasquillo, Minerva M., Karhade, Aditya, Manly, Lester, Burgess, Jeremy D., Wang, Chen, Serie, Daniel, Wang, Xue, Siuda, Joanna, Zou, Fanggeng, Chai, High Seng, Younkin, Curtis, Crook, Julia, Medway, Christopher, Nguyen, Thuy, Ma, Li, Malphrus, Kimberly, Lincoln, Sarah, Petersen, Ronald C., Graff-Radford, Neill R., Asmann, Yan W., Dickson, Dennis W., Younkin, Steven G., Ertekin-Taner, Nilüfer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807909/ https://www.ncbi.nlm.nih.gov/pubmed/27066552 http://dx.doi.org/10.1212/NXG.0000000000000012

Ejemplares similares

African American exome sequencing identifies potential risk variants at Alzheimer disease loci
por: N'Songo, Aurelie, et al.
Publicado: (2017)

Human whole genome genotype and transcriptome data for Alzheimer’s and other neurodegenerative diseases
por: Allen, Mariet, et al.
Publicado: (2016)

Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels
por: Allen, Mariet, et al.
Publicado: (2014)

LRRTM3 Interacts with APP and BACE1 and Has Variants Associating with Late-Onset Alzheimer’s Disease (LOAD)
por: Lincoln, Sarah, et al.
Publicado: (2013)

Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsy
por: Allen, Mariet, et al.
Publicado: (2018)

Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer’s disease brains
por: Ma, Li, et al.
Publicado: (2016)

ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease
por: Medway, Christopher W, et al.
Publicado: (2014)

ABCA7 loss-of-function variants, expression, and neurologic disease risk
por: Allen, Mariet, et al.
Publicado: (2017)

Brain Expression Genome-Wide Association Study (eGWAS) Identifies Human Disease-Associated Variants
por: Zou, Fanggeng, et al.
Publicado: (2012)

Correction to: Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
por: Wang, Xue, et al.
Publicado: (2020)

Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
por: Wang, Xue, et al.
Publicado: (2020)

Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications
por: Allen, Mariet, et al.
Publicado: (2012)

Plasma Biomarkers of Alzheimer’s Disease in African Americans
por: Deniz, Kaancan, et al.
Publicado: (2021)

Linking Protective GAB2 Variants, Increased Cortical GAB2 Expression and Decreased Alzheimer’s Disease Pathology
por: Zou, Fanggeng, et al.
Publicado: (2013)

Alzheimer’s disease and progressive supranuclear palsy share similar transcriptomic changes in distinct brain regions
por: Wang, Xue, et al.
Publicado: (2022)

Investigation of 15 of the top candidate genes for late-onset Alzheimer’s disease
por: Belbin, Olivia, et al.
Publicado: (2010)

TMEM106B haplotypes have distinct gene expression patterns in aged brain
por: Ren, Yingxue, et al.
Publicado: (2018)

Genetically-controlled Vesicle-Associated Membrane Protein 1 expression may contribute to Alzheimer’s pathophysiology and susceptibility
por: Sevlever, Daniel, et al.
Publicado: (2015)

Transcript levels in plasma contribute substantial predictive value as potential Alzheimer's disease biomarkers in African Americans
por: Reddy, Joseph S., et al.
Publicado: (2022)

Erratum to: Genetically-controlled Vesicle-Associated Membrane Protein 1 expression may contribute to Alzheimer’s pathophysiology and susceptibility
por: Sevlever, Daniel, et al.
Publicado: (2015)

ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans
por: Conway, Olivia J, et al.
Publicado: (2018)

Impact of variant-level batch effects on identification of genetic risk factors in large sequencing studies
por: Wickland, Daniel P., et al.
Publicado: (2021)

Latent trait modeling of tau neuropathology in progressive supranuclear palsy
por: Kouri, Naomi, et al.
Publicado: (2021)

Clinical Deep Phenotyping of ABCA7 Mutation Carriers
por: Campbell, Alana S., et al.
Publicado: (2022)

Genome-wide analysis identifies a novel LINC-PINT splice variant associated with vascular amyloid pathology in Alzheimer’s disease
por: Reddy, Joseph S., et al.
Publicado: (2021)

Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study
por: Carrasquillo, Minerva M, et al.
Publicado: (2011)

Integrative functional genomic analysis of intron retention in human and mouse brain with Alzheimer's disease
por: Li, Hong‐Dong, et al.
Publicado: (2021)

Concordant Association of Insulin Degrading Enzyme Gene (IDE) Variants with IDE mRNA, Aß, and Alzheimer's Disease
por: Carrasquillo, Minerva M., et al.
Publicado: (2010)

Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy
por: Strickland, Samantha L., et al.
Publicado: (2020)

An intronic PICALM polymorphism, rs588076, is associated with allelic expression of a PICALM isoform
por: Parikh, Ishita, et al.
Publicado: (2014)

Rheumatoid arthritis-associated polymorphisms are not protective against Alzheimer's disease
por: Simmons, Christopher R, et al.
Publicado: (2011)

Evaluation of the global association between cholesterol-associated polymorphisms and Alzheimer's disease suggests a role for rs3846662 and HMGCR splicing in disease risk
por: Simmons, Christopher R, et al.
Publicado: (2011)

Systematic analysis of dark and camouflaged genes reveals disease-relevant genes hiding in plain sight
por: Ebbert, Mark T. W., et al.
Publicado: (2019)

TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer’s disease
por: Chakrabarty, Paramita, et al.
Publicado: (2018)

Multiple Insulin Degrading Enzyme Variants Alter In Vitro Reporter Gene Expression
por: Belbin, Olivia, et al.
Publicado: (2011)

Apolipoprotein E regulates lipid metabolism and α-synuclein pathology in human iPSC-derived cerebral organoids
por: Zhao, Jing, et al.
Publicado: (2021)

The SERPINA5 coding variant E228Q does not contribute to clinicopathologic characteristics in Alzheimer’s disease: A cross-sectional study
por: Matchett, Billie J., et al.
Publicado: (2023)

TREM2 is associated with increased risk for Alzheimer’s disease in African Americans
por: Jin, Sheng Chih, et al.
Publicado: (2015)

Transcriptomic analysis to identify genes associated with selective hippocampal vulnerability in Alzheimer’s disease
por: Crist, Angela M., et al.
Publicado: (2021)

Ethnoracial differences in Alzheimer’s disease from the FLorida Autopsied Multi-Ethnic (FLAME) cohort
por: Santos, Octavio A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lbh57fia499bu87oob0v74rbl8